Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

37.18
+0.42321.15%
Volume:1K
Turnover:48.43K
Market Cap:17.47M
PE:- -
High:37.49
Open:37.49
Low:37.11
Close:36.75
52wk High:37.90
52wk Low:28.87
Shares:469.95K
Float Shares:469.95K
Volume Ratio:0.59
T/O Rate:0.28%
Dividend:0.41
Dividend Rate:1.10%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS
·
Aug 27

Innovative Drug Sector Resurgence: Fund Manager Breaks Down the Rally's Driving Forces

Deep News
·
Aug 27

Eli Lilly & Co. Stock Slips 3.6%, Underperforms Peers

Dow Jones
·
Aug 27

AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 27

Sector Update: Healthcare

MT Newswires Live
·
Aug 27

US FDA - Issues Early Alert on Abiomed Heart Pump Controller Purge Cassette Issue

THOMSON REUTERS
·
Aug 27

Eli Lilly Expands Alzheimer’s Pipeline With New Amyloid Phase 1 Trial

TIPRANKS
·
Aug 27

Eli Lilly Stock (LLY) in Focus as Alzheimer’s Blood Test Gets FDA Approval

TIPRANKS
·
Aug 26

Boston Scientific Hit by Cyberattack, Shares Slide on Delivery Disruption

Deep News
·
Aug 26

Unlocking Pipeline Value: Discovering A-Share Innovative Drug Investment Opportunities Through a DCF Lens

Deep News
·
Aug 26

China's Top Innovative Drugmaker Sees Profits Surge Sixfold, Market Cap Reaches 430 Billion Yuan

Deep News
·
Aug 26

Eli Lilly and Co Stock (LLY) Opened Down by 3.57% on Aug 26: Facts Behind the Movement

TradingKey
·
Aug 26

IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001

GlobeNewswire
·
Aug 26

Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer

GlobeNewswire
·
Aug 26

Eli Lilly Study Shows Lower Healthcare Costs With Zepbound in Older Adults

MT Newswires Live
·
Aug 26

Gubra Earns USD 50 Million Milestone as AbbVie Starts Phase 2 Trial of Obesity Drug ABBV-295

Reuters
·
Aug 26

Financial Heavyweights Drive Gains as Multiple Sectors Rally on Policy Support and Solid Earnings

Deep News
·
Aug 26

Shanghai Sets Ambitious Target: Strategic Emerging Industries to Hit 2.1 Trillion Yuan in Value-Added Output by 2030

Deep News
·
Aug 26

Zepbound Linked to Lower Healthcare Costs in Adults over Age 55 with Obesity According to a Real-World Study

THOMSON REUTERS
·
Aug 26

Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes

Reuters
·
Aug 26